Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
This study is designed to determine the safety and tolerability of a single microinjection of
triamcinolone acetonide (TRIESENCE®) into the suprachoroidal space (SCS) of patients who have
non-infectious uveitis.